CMT2A Research

CMT2A CMT2A is caused by dominant mutations in Mitofusin 2 (MFN2). The STAR team has developed two excellent rat models for CMT2A which are being made available to the research…

CMTA Report Fall 2021

…in The CMTA Report pertains to you. The CMTA assumes no liability for any information in The CMTA Report. ISSN #1067-0181 Vol. 36, No. 2 Email the CMTA at info@cmtausa.org…

2021_Winter_CMTA_Report

…Community Outreach, laurel@cmtausa.org Jeana Sweeney Director of Development, jeana@cmtausa.org INSIDE THIS ISSUE: RESEARCH Board Approves Grants for Inhibitor Work ………….7 CMT STORIES Filmmaker Doesn’t Let CMT Stop Her ………………….6 Educator…

CMTA Volunteer Spotlight

…laurel@cmtausa.org. CMTActive on Facebook (www.facebook.com/groups/cmtactive/) Benjy Hershorn (CMTActive Moderator and Houston Branch Leader) My name is Benjy Hershorn. Although born and raised in Kansas, I got to Texas “as fast…

X-linked CMT

…CMT1X/X1 is the second most common CMT subtype, accounting for approximately 17% of all CMT cases, second only to CMT1A, which accounts for approximately 60% of all CMT cases. The…

2017_Fall_CMTA_Report

…Developed stem cell lines from CMT1A patients which will be used to validate promising compounds. MILLION 2.8 CMT1A CMTA-funded researchers have identified promising drug candidates for CMT1A. One of them…

2017_Fall_CMTA_Report

…Developed stem cell lines from CMT1A patients which will be used to validate promising compounds. MILLION 2.8 CMT1A CMTA-funded researchers have identified promising drug candidates for CMT1A. One of them…

CMTAreportSummer2022web

…to you. The CMTA assumes no liability for any information in The CMTA Report. ISSN #1067-0181 Vol. 37, No. 2 Email the CMTA at info@cmtausa.org THE CMTA REPORT | SUMMER…